Research Reveals Unique Solution to Gene Regulation
Research on a unique vertebrate called the sea lamprey shows that more than a thousand genes are shed during its early development and "sealed' into a compartment so they cannot be misexpressed and...
View ArticleStudy Attempts to Reverse Autoimmunity in Type 1 Diabetes
Results from a novel experimental therapy for type 1 diabetes that boosts parts of the healthy immune system were reported today. The trial was led by Carla Greenbaum, MD, Diabetes Research Program at...
View ArticleNew Grant Awards Aim to Prevent Autoimmune Diseases
Benaroya Research Institute at Virginia Mason (BRI) recently received two major grant awards to explore how to regulate the immune system, as part of a nationwide collaborative program to prevent...
View ArticleCollaborative Grant Looks for Genetic Roots of Type 1 Diabetes
In a new $4.3 million grant from the NIH, scientists from Benaroya Research Institute at Virginia Mason, Seattle Children's Research Institute and University of Virginia combine their expertise in...
View ArticleBRI Receives Grand Challenges Explorations Grant
BRI announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation. Brad Stone, PhD, Principal Investigator for the grant, will...
View ArticlePuget Sound Buildings Turn Blue for World Diabetes Day
On Nov. 14th, World Diabetes Day, 12 Puget Sound area diabetes organizations and landmarks will identify Seattle as a global leader in diabetes research and clinical care by joining the "Blue Monument...
View ArticleResearchers Identify Potential Therapy Target in MS
Findings offer a better understanding of the development and progression of multiple sclerosis and potential future therapeutic target.
View ArticleBRI Receives $4.4 Million Type 1 Diabetes Grant
Benaroya Research Institute establishes the T1D Exchange Biobank Operations Center to advance discoveries in type 1 diabetes research with biosamples from thousands of participants.
View ArticleClik here to view.
Coelacanth Genome Informs Land Vertebrate Evolution
International researchers led by Chris Amemiya, PhD, Benaroya Research Institute at Virginia Mason, has published "The African coelacanth genome provides insights into tetrapod evolution" as the cover...
View ArticleResearchers Use Web 2.0 Apps to Share Vaccine Study
Research utilizing a systems approach demonstrates that different vaccines lead to immunity via distinct immune response pathways. Published findings include interactive figures linked to the...
View ArticleFirst Study to Investigate the Human Genome in Multiple Sclerosis
The National Institutes of Health (NIH) awarded Benaroya Research Institute at Virginia Mason (BRI) a $1.9 million grant to find marks in the human genome which can explain why some white blood cells...
View ArticleBenaroya Research Institute Evaluates Immunology Approach to Blocking Breast...
Benaroya Research Institute (BRI) received a grant to research how blocking a particular molecule in metastatic breast cancer reduces both the growth of primary tumors and the number of lung...
View ArticleBenaroya Research Institute Scientists Identify Drivers of Rheumatoid Arthritis
Researchers at Benaroya Research Institute at Virginia Mason (BRI) used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA).
View ArticleBenaroya Research Institute Receives $2.2 Million to Discover Biomarker That...
Scientists at Benaroya Research Institute at Virginia Mason (BRI) recently received a $2.2 million grant from the NIH to find a unique biomarker that initiates and drives allergies. This grant expands...
View ArticleBenaroya Research Institute to Unravel Insulin Mystery in Type 1 Diabetes
Benaroya Research Institute has received a $1.4 million grant from JDRF to understand why some people with type 1 diabetes maintain the ability to produce insulin. Researchers have found at the time of...
View ArticleOne in Every Three People with Type 1 Diabetes Produces Insulin Years...
About one-third of people with type 1 diabetes (T1D) produce insulin, as measured by C-peptide, a byproduct of insulin production, even upward of forty years from initial diagnosis, according to a...
View ArticleChitin, a Structural Molecule Associated with Allergy Response in Mammals is...
Scientists at Benaroya Research Institute at Virginia Mason (BRI) have made an unexpected discovery that overturns a longstanding belief in the biological sciences. The research demonstrates that...
View ArticleBenaroya Research Institute Will Receive $750,000 for Food Allergy Research
Erik Wambre, PhD, an immunology and allergy researcher at Benaroya Research Institute at Virginia Mason (BRI), has received a Mid-Career Investigators Award from Food Allergy Research & Education...
View ArticleBenaroya Research Institute at Virginia Mason Announces Plans for Leadership...
Gerald Nepom, MD, PhD, who has served as director of Benaroya Research Institute at Virginia Mason (BRI) for 30 years, will retire from this position at the end of 2015. He will be succeeded by Jane...
View ArticleBRI's Carla Greenbaum, MD, Named Chair of Type 1 Diabetes TrialNet
Carla J. Greenbaum, MD, has been named chair of Type 1 Diabetes TrialNet, the National Institutes of Health (NIH) funded clinical trial network for type 1 diabetes prevention and early treatment.
View Article
